|
2025
|
Invention
|
Nucleic acids encoding human endogenous retrovirus k (herv-k) envelope proteins containing modifi... |
|
|
Invention
|
Vaccine for use in the prophylaxis and/or treatment of a disease.
A vaccine for use in the proph... |
|
2024
|
Invention
|
Improved expression of surface-displayed antigens. The present invention relates to a composition... |
|
|
P/S
|
Pharmaceuticals for immunotherapy and cancer therapy; medical and veterinary preparations for tre... |
|
|
Invention
|
Vaccine for use in the prophylaxis and/or treatment of a disease. The present invention relates t... |
|
2023
|
Invention
|
Chimeric vlp forming polypeptides comprising beta-retroviral gag. The present invention relates t... |
|
|
P/S
|
Pharmaceuticals; medical and veterinary preparations; Substances adapted for medical or veterinar... |
|
2022
|
Invention
|
Therapeutic papilloma virus vaccines.
The present invention relates to a nucleic acid comprising... |
|
|
Invention
|
Therapeutic papilloma virus vaccines. The present invention relates to a nucleic acid comprising ... |
|
2020
|
P/S
|
Pharmaceutical preparations based on human antibodies for the treatment of cancer; veterinary pre... |
|
2019
|
P/S
|
Pharmaceutical, veterinary and sanitary preparations, including pharmaceutical preparations based... |
|
|
Invention
|
A vaccine for use in the prophylaxis and/or treatment of a disease. The present invention relates... |
